| 01/26 | Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests o.. | BU |
| 01/25 | Investor Group Issues Letter to the Boards of Sesen Bio and Carisma Rejecting Their App.. | BU |
| 01/19 | Sesen Bio Files Definitive Proxy Statement and Mails Letter to Stockholders in Connecti.. | BU |
| 01/05 | Investor Group Issues Letter to Sesen Bio's Board of Directors Regarding Intent to Vote.. | BU |
| 01/04 | Sesen Bio Reiterates Confidence in Pending Merger with Carisma Therapeutics | BU |
| 01/03 | Investor Group Reiterates Intent to Vote AGAINST Sesen Bio's Value-Destructive Merger w.. | BU |
| 2022 | Sesen Bio, Inc. : Entry into a Material Definitive Agreement, Other Events, Financial Stat.. | AQ |
| 2022 | Sesen Bio and Carisma Therapeutics Announce Substantial Increase to Expected Special Ca.. | BU |
| 2022 | Sesen Bio : Termination of Material Agreement - Form 8-K | PU |
| 2022 | Sesen Bio, Inc. : Termination of a Material Definitive Agreement (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Other Events (form 8-K) | AQ |
| 2022 | Sesen Bio Reports Third Quarter 2022 Financial Results and Business Update | BU |
| 2022 | SESEN BIO, INC. Management's Discussion and Analysis of Financial Condition and
Result.. | AQ |
| 2022 | Sesen Bio, Inc. : Other Events (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Other Events (form 8-K) | AQ |
| 2022 | Carisma and Sesen Bio Combine, Raise $30M for CAR-M Therapeutics | AQ |
| 2022 | Sesen Bio Investor Alert By The Form : Kahn Swick & Foti, LLC Investigates Merger of Sesen.. | BU |
| 2022 | Sesen Bio and Carisma Therapeutics Announce Merger Agreement | BU |
| 2022 | Sesen Bio, Inc. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Fi.. | AQ |
| 2022 | Sesen Bio, Inc. : Other Events (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Change in Directors or Principal Officers (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 2022 | SESEN BIO, INC. Management's Discussion and Analysis of Financial Condition and
Result.. | AQ |
| 2022 | Sesen Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 2022 | Sesen Bio : Costs Associated with Exit or Disposal Activities - Form 8-K/A | PU |
| 2022 | SESEN BIO, INC. Costs Associated with Exit or Disposal Activities (form 8-K/A) | AQ |
| 2022 | SESEN BIO, INC. Management's Discussion and Analysis of Financial Condition and
Result.. | AQ |
| 2022 | Sesen Bio Reports Second Quarter 2022 Financial Results and Business Update | BU |
| 2022 | Sesen Bio, Inc. : Other Events (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Termination of a Material Definitive Agreement (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Costs Associated with Exit or Disposal Activities (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Entry into a Material Definitive Agreement, Termination of a Material De.. | AQ |
| 2022 | Sesen Bio, Inc. : Results of Operations and Financial Condition, Other Events, Financial S.. | AQ |
| 2022 | Sesen Bio Announces Strategic Decision to Pause Clinical Development of Vicineum™.. | BU |
| 2022 | Sesen Bio, Inc. : Other Events (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Other Events (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Regulation FD Disclosure (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Regulation FD Disclosure (form 8-K) | AQ |
| 2022 | Sesen Bio Reports First Quarter 2022 Financial Results and Business Update | BU |
| 2022 | SESEN BIO, INC. Management's Discussion and Analysis of Financial Condition and
Result.. | AQ |
| 2022 | Sesen Bio Provides Strategic Update | BU |
| 2022 | Sesen Bio, Inc. : Results of Operations and Financial Condition, Other Events, Financial S.. | AQ |
| 2022 | Sesen Bio, Inc. : Other Events (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Other Events (form 8-K) | AQ |
| 2022 | SESEN BIO, INC. Management's Discussion and Analysis of Financial Condition and Result.. | AQ |
| 2022 | Sesen Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Anticipated R.. | BU |
| 2022 | Sesen Bio, Inc. : Other Events (form 8-K) | AQ |
| 2022 | Sesen Bio, Inc. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St.. | AQ |
| 2022 | Sesen Bio, Inc. : Regulation FD Disclosure (form 8-K) | AQ |
| 2022 | Sesen Bio Further Enhances Team with Key Hires | BU |
| 2022 | Sesen Bio, Inc. : Regulation FD Disclosure (form 8-K) | AQ |
| 2021 | Sesen Bio Announces Anticipated Regulatory Path Forward for Vicineum™ | BU |
| 2021 | Sesen Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 2021 | Sesen Bio Strengthens Medical Team | BU |
| 2021 | Sesen Bio Director Jane Pritchett Henderson Transitions to CEO Advisor Role | BU |
| 2021 | Sesen Bio, Inc. : Change in Directors or Principal Officers, Financial Statements and Exhi.. | AQ |
| 2021 | Sesen Bio, Inc. : Regulation FD Disclosure (form 8-K) | AQ |
| 2021 | Sesen Bio Reports Third Quarter 2021 Financial Results and Business Update | BU |
| 2021 | SESEN BIO, INC. Management's Discussion and Analysis of Financial Condition and
Result.. | AQ |
| 2021 | Sesen Bio Announces Productive CMC Type A Meeting with the FDA | BU |
| 2021 | Sesen Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 2021 | Sesen Bio, Inc. : Other Events (form 8-K) | AQ |
| 2021 | Sesen Bio, Inc. : Regulation FD Disclosure (form 8-K) | AQ |
| 2021 | Sesen Bio : Expands CMC and Clinical Teams | BU |
| 2021 | Sesen Bio, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 2021 | Sesen Bio, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 2021 | Sesen Bio, Inc. : Change in Directors or Principal Officers (form 8-K) | AQ |
| 2021 | Sesen Bio, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 2021 | Sesen Bio : Costs Associated with Exit or Disposal Activities (Form 8-K) | PU |
| 2021 | Sesen Bio, Inc. : Costs Associated with Exit or Disposal Activities (form 8-K) | AQ |
| 2021 | Sesen Bio, Inc. : Other Events (form 8-K) | AQ |
| 2021 | Sesen Alert : Bragar Eagel & Squire, P.C. is Investigating Sesen Bio, Inc. on Behalf of Se.. | BU |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
